Cartilage quality in rheumatoid arthritis: comparison of T2* mapping, native T1 mapping, dGEMRIC, ΔR1 and value of pre-contrast imaging

[1]  S. Trattnig,et al.  Biochemical evaluation of articular cartilage in patients with osteochondrosis dissecans by means of quantitative T2- and T2-mapping at 3T MRI: a feasibility study. , 2012, European journal of radiology.

[2]  Siegfried Trattnig,et al.  T2 star relaxation times for assessment of articular cartilage at 3 T: a feasibility study , 2012, Skeletal Radiology.

[3]  Matthias Schneider,et al.  Motion correction improves image quality of dGEMRIC in finger joints. , 2011, European journal of radiology.

[4]  P. Leboit,et al.  Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. , 2011, Journal of the American Academy of Dermatology.

[5]  Tarik K Alkasab,et al.  Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. , 2011, Radiology.

[6]  J. Smolen,et al.  Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction , 2011, Annals of the rheumatic diseases.

[7]  M. Prince,et al.  Incidence of immediate gadolinium contrast media reactions. , 2011, AJR. American journal of roentgenology.

[8]  G. Berglund,et al.  Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[9]  Matthias Schneider,et al.  Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage--a feasibility study. , 2010, Radiology.

[10]  J. Svensson,et al.  Knee cartilage quality assessed with dGEMRIC in rheumatoid arthritis patients before and after treatment with a TNF inhibitor , 2010, Acta radiologica.

[11]  D. Symmons,et al.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. , 2010, Arthritis and rheumatism.

[12]  Hollis G Potter,et al.  Using Magnetic Resonance Angiography to Measure Abnormal Synovial Blood Vessels in Early Inflammatory Arthritis: A New Imaging Biomarker? , 2010, The Journal of Rheumatology.

[13]  M. Østergaard,et al.  Uncoupling of Collagen II Metabolism in Newly Diagnosed, Untreated Rheumatoid Arthritis Is Linked to Inflammation and Antibodies Against Cyclic Citrullinated Peptides , 2010, The Journal of Rheumatology.

[14]  N. Dalbeth,et al.  Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system , 2010, Annals of the rheumatic diseases.

[15]  Roland Chapurlat,et al.  A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis. , 2010, Joint, bone, spine : revue du rhumatisme.

[16]  K. Siebenrock,et al.  Delayed gadolinium‐enhanced magnetic resonance imaging (dGEMRIC) of hip joint cartilage in femoroacetabular impingement (FAI): Are pre‐ and postcontrast imaging both necessary? , 2009, Magnetic resonance in medicine.

[17]  Klaus A Siebenrock,et al.  Feasibility of T  2* mapping for the evaluation of hip joint cartilage at 1.5T using a three‐dimensional (3D), gradient‐echo (GRE) sequence: A prospective study , 2009, Magnetic resonance in medicine.

[18]  Deborah Burstein,et al.  Measures of molecular composition and structure in osteoarthritis. , 2009, Radiologic clinics of North America.

[19]  Ying Wu,et al.  Value of precontrast T1 for dGEMRIC of native articular cartilage , 2009, Journal of magnetic resonance imaging : JMRI.

[20]  J. Smolen,et al.  Does damage cause inflammation? Revisiting the link between joint damage and inflammation , 2009, Annals of the rheumatic diseases.

[21]  D. Burstein,et al.  Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences , 2008, Magnetic resonance in medicine.

[22]  A. Falus,et al.  Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis , 2008, Arthritis research & therapy.

[23]  Klaus Scheffler,et al.  In Vivo Biochemical 7.0 Tesla Magnetic Resonance: Preliminary Results of dGEMRIC, Zonal T2, and T2* Mapping of Articular Cartilage , 2008, Investigative radiology.

[24]  David Moratal,et al.  MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions , 2008, Journal of magnetic resonance imaging : JMRI.

[25]  M. Deimling,et al.  Three‐dimensional delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) for in vivo evaluation of reparative cartilage after matrix‐associated autologous chondrocyte transplantation at 3.0T: Preliminary results , 2007 .

[26]  Wilhelm Horger,et al.  Quantitative T2 Mapping of Matrix-Associated Autologous Chondrocyte Transplantation at 3 Tesla: An In Vivo Cross-Sectional Study , 2007, Investigative radiology.

[27]  A. Bjørnerud,et al.  Contrast-enhanced dynamic magnetic resonance imaging of finger joints in osteoarthritis and rheumatoid arthritis: an analysis based on pharmacokinetic modeling , 2006, Acta radiologica.

[28]  Takayuki Obata,et al.  Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: preliminary results. , 2006, Radiology.

[29]  D. Heinegård,et al.  Prognostic laboratory markers of joint damage in rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[30]  Enzo Silvestri,et al.  Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. , 2003, Arthritis and rheumatism.

[31]  Carl Johan Tiderius,et al.  Delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis , 2003, Magnetic resonance in medicine.

[32]  Deborah Burstein,et al.  Relaxivity and diffusion of gadolinium agents in cartilage , 2002, Magnetic resonance in medicine.

[33]  D. Burstein,et al.  Magnetic Resonance Imaging of Relative Glycosaminoglycan Distribution in Patients with Autologous Chondrocyte Transplants , 2001, Investigative radiology.

[34]  P Leander,et al.  Gd‐DTPA2–‐enhanced MRI of femoral knee cartilage: A dose‐response study in healthy volunteers , 2001, Magnetic resonance in medicine.

[35]  K. T. Scott,et al.  Protocol issues for delayed Gd(DTPA)2–‐enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage , 2001, Magnetic resonance in medicine.

[36]  D. Burstein,et al.  Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. , 1997, Radiology.

[37]  D. Burstein,et al.  Gd‐DTPA2− as a measure of cartilage degradation , 1996, Magnetic resonance in medicine.

[38]  O. Henriksen,et al.  Dynamic gadolinium-enhanced MR imaging in active and inactive immunoinflammatory gonarthritis. , 1994, Acta radiologica.

[39]  G. R. Dodge,et al.  The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. , 1991, Matrix.

[40]  P. Dieppe,et al.  Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro , 1991, Clinical and experimental immunology.

[41]  R. Lanzman,et al.  Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them , 2009, Skeletal Radiology.

[42]  C. Glaser,et al.  P87 Quantitative T2 mapping of matrix-associated autologous chondrocyte transplantation at 3T: an in vivo cross-sectional study , 2007 .

[43]  A. D. Brett,et al.  Measurement of cartilage volumes in rheumatoid arthritis using MRI. , 2005, The British journal of radiology.